OraSure Technologies, Inc. (OSUR) Updates Q2 Earnings Guidance
OraSure Technologies, Inc. (NASDAQ:OSUR) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided earnings per share guidance of ~$0.01-0.02 for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($0.09), Analyst Ratings News reports. The company issued revenue guidance of $26.0-26.5 million, compared to the consensus revenue estimate of $26.24 million.
Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of OraSure Technologies from a neutral rating to an outperform rating in a research note on Tuesday. They now have a $9.20 price target on the stock. On a related note, analysts at Jefferies Group reiterated a buy rating on shares of OraSure Technologies in a research note on Thursday, June 12th. They now have a $10.00 price target on the stock, up previously from $9.00. Finally, analysts at Raymond James raised their price target on shares of OraSure Technologies from $8.50 to $9.00 in a research note on Thursday, June 12th. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of Buy and an average price target of $9.70.
OraSure Technologies, Inc. (NASDAQ:OSUR) opened at 8.36 on Wednesday. OraSure Technologies, Inc. has a 52-week low of $3.75 and a 52-week high of $9.00. The stock’s 50-day moving average is $6. and its 200-day moving average is $6.82. The company’s market cap is $466.8 million.
OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.03. The company had revenue of $23.50 million for the quarter, compared to the consensus estimate of $23.28 million. During the same quarter in the previous year, the company posted ($0.18) earnings per share. The company’s revenue for the quarter was up 10.8% on a year-over-year basis. On average, analysts predict that OraSure Technologies, Inc. will post $-0.22 earnings per share for the current fiscal year.
OraSure Technologies, Inc, is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using the Company’s oral fluid technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.